Drug to treat rare kidney disease to be reviewed by EMA
The European Medicines Agency (EMA) has agreed to review a conditional marketing authorization (CMA) application…
August 22, 2022 - 3 minutes
The European Medicines Agency (EMA) has agreed to review a conditional marketing authorization (CMA) application…